No biomarker	Multiple Myeloma	No biomarker	Multiple Myeloma	dexamethasone tablets Sensitive: A1 - Approval dexamethasone tablets Sensitive : A1	dexamethasone tablets Sensitive: A1 - Approval dexamethasone tablets Sensitive : A1
No biomarker	Multiple Myeloma	No biomarker	Multiple Myeloma	venetoclax Sensitive: A2 - Guideline venetoclax Sensitive : A2	venetoclax Sensitive: A2 - Guideline venetoclax Sensitive : A2
No biomarker	Childhood B Acute Lymphoblastic Leukemia	No biomarker	Childhood B Acute Lymphoblastic Leukemia	vincristine + mitoxantrone + pegaspargase Sensitive: A2 - Guideline vincristine + mitoxantrone + pegaspargase Sensitive : A2	vincristine + mitoxantrone + pegaspargase Sensitive: A2 - Guideline vincristine + mitoxantrone + pegaspargase Sensitive : A2
No biomarker	Diffuse Large B Cell Lymphoma	No biomarker	Diffuse Large B Cell Lymphoma	carboplatin + gemcitabine + rituximab Sensitive: A2 - Guideline carboplatin + gemcitabine + rituximab Sensitive : A2	carboplatin + gemcitabine + rituximab Sensitive: A2 - Guideline carboplatin + gemcitabine + rituximab Sensitive : A2
No biomarker	Diffuse Large B Cell Lymphoma	No biomarker	Diffuse Large B Cell Lymphoma	carboplatin + gemcitabine Sensitive: A2 - Guideline carboplatin + gemcitabine Sensitive : A2	carboplatin + gemcitabine Sensitive: A2 - Guideline carboplatin + gemcitabine Sensitive : A2
No biomarker	B Acute Lymphoblastic Leukemia	No biomarker	B Acute Lymphoblastic Leukemia	Tyrosine kinase inhibitor + vincristine Sensitive: A2 - Guideline Tyrosine kinase inhibitor + vincristine Sensitive : A2	Tyrosine kinase inhibitor + vincristine Sensitive: A2 - Guideline Tyrosine kinase inhibitor + vincristine Sensitive : A2
No biomarker	Non-Hodgkin’s Lymphoma	No biomarker	Non-Hodgkin’s Lymphoma	carboplatin + cytarabine Sensitive: A2 - Guideline carboplatin + cytarabine Sensitive : A2	carboplatin + cytarabine Sensitive: A2 - Guideline carboplatin + cytarabine Sensitive : A2
No biomarker	T Cell Non-Hodgkin Lymphoma	No biomarker	T Cell Non-Hodgkin Lymphoma	carboplatin + cytarabine Sensitive: A2 - Guideline carboplatin + cytarabine Sensitive : A2	carboplatin + cytarabine Sensitive: A2 - Guideline carboplatin + cytarabine Sensitive : A2
No biomarker	Follicular Lymphoma	No biomarker	Follicular Lymphoma	carboplatin + cytarabine Sensitive: A2 - Guideline carboplatin + cytarabine Sensitive : A2	carboplatin + cytarabine Sensitive: A2 - Guideline carboplatin + cytarabine Sensitive : A2
No biomarker	Peripheral T-cell Lymphoma	No biomarker	Peripheral T-cell Lymphoma	carboplatin + cytarabine Sensitive: A2 - Guideline carboplatin + cytarabine Sensitive : A2	carboplatin + cytarabine Sensitive: A2 - Guideline carboplatin + cytarabine Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate Sensitive: A2 - Guideline abiraterone acetate Sensitive : A2	abiraterone acetate Sensitive: A2 - Guideline abiraterone acetate Sensitive : A2
No biomarker	Multiple Myeloma	No biomarker	Multiple Myeloma	venetoclax + bortezomib Sensitive: B - Late Trials venetoclax + bortezomib Sensitive : B	venetoclax + bortezomib Sensitive: B - Late Trials venetoclax + bortezomib Sensitive : B

GCR agonist

GCR agonist

Associations(1)

Associations
(1)